Sucampo announced that its development partner, R-Tech Ueno, has completed enrollment for a phase 3 study of unoprostone isopropyl ophthalmic solution 0.15% for the treatment of retinitis pigmentosa, according to a news release. The randomized, double-blind, placebo-controlled study, to be conducted at 38 medical institutions in Japan, will evaluate whether unoprostone isopropyl ophthalmic solution improves central retinal sensitivity in patients with retinitis pigmentosa. The study’s target sample size is 180 patients, according to the release.
What is contact lens discomfort, why does it occur and how can it be treated?
Contact lens discomfort (CLD) may be the leading cause of patient dissatisfaction with, and discontinuation of, contact lens wear throughout the world – but there is little agreement among vision researchers and eye care professionals about how to defi…
No evidence to support stem cell therapy for pediatric optic nerve hypoplasia
A study performed at Children’s Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia (ONH). Their results are reported in the Journal of the American Association for Pediatric Ophthalmol…
Study finds no evidence that stem cell therapy improves vision for children with ONH
A study performed at Children’s Hospital Los Angeles found no evidence that stem cell therapy improves vision for children with optic nerve hypoplasia. Their results are reported in the Journal of the American Association for Pediatric Ophthalmology an…
Adalimumab may be viable treatment option for patients with refractory pediatric uveitis
A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients with steroid-resistant re…
UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men
The National Institute on Drug Abuse has awarded UCLA a $7 million grant to investigate the links between substance abuse and HIV among Latino and African-American men who have sex with men.